Short Interest in Acacia Pharma Group plc (OTCMKTS:ACPGF) Declines By 68.0%

Acacia Pharma Group plc (OTCMKTS:ACPGFGet Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 198,400 shares, a drop of 68.0% from the March 15th total of 620,800 shares. Based on an average daily trading volume, of 7,200 shares, the short-interest ratio is currently 27.6 days.

Acacia Pharma Group stock opened at $0.92 on Wednesday. Acacia Pharma Group has a 1-year low of $0.80 and a 1-year high of $4.00. The stock’s fifty day moving average is $1.34 and its two-hundred day moving average is $1.64.

Acacia Pharma Group Company Profile (Get Rating)

Acacia Pharma Group plc, a hospital pharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, other invasive procedures, or cancer chemotherapy treatments in the United States and internationally. The company's lead product is BARHEMSYS, an intravenous amisulpride for the treatment and prophylaxis of post-operative nausea and vomiting.

Featured Articles

Receive News & Ratings for Acacia Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acacia Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.